Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GENE | AMGN | BMY | GILD | VRTX |
| Company | Genetic Tech Spn ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 3.38 | 269.93 | 48.36 | 68.27 | 400.00 |
| High | 3.38 | 270.93 | 49.10 | 68.46 | 402.49 |
| Low | 3.21 | 264.35 | 48.12 | 67.70 | 396.69 |
| Last | 3.27 | 265.51 | 48.51 | 67.75 | 397.36 |
| Change | -0.05 | -1.77 | +0.23 | -0.32 | +0.81 |
| % Change | -1.53% | -0.66% | +0.48% | -0.47% | +0.20% |
| Volume | 15,700 | 1,740,100 | 11,943,600 | 7,717,800 | 1,373,700 |
| 20-Day Average Volume | 36,350 | 2,348,660 | 11,927,375 | 6,525,295 | 912,345 |
| Previous Close | 3.32 | 267.28 | 48.28 | 68.07 | 396.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.83 | 274.13 | 51.53 | 71.23 | 409.48 |
| 20-Day Raw Stochastic | 73.99% | 4.81% | 6.14% | 1.95% | 13.00% |
| 20-Day Relative Strength | 67.08% | 38.68% | 36.92% | 31.69% | 39.01% |
| Weighted Alpha | -23.55 | +5.78 | -29.74 | -22.75 | +17.20 |
| Today's Opinion | 24% Buy | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 24% Buy | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 40% Sell | 8% Sell | 8% Sell | 40% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.96% since 04/08/24 | -1.37% since 04/08/24 | -5.07% since 04/08/24 | -2.41% since 04/08/24 | -1.70% since 04/08/24 |
| Low | 2.86 on 04/09/24 | 264.35 on 04/15/24 | 48.12 on 04/15/24 | 67.62 on 04/12/24 | 393.76 on 04/12/24 |
| High | 3.59 on 04/12/24 | 273.00 on 04/11/24 | 51.68 on 04/09/24 | 69.95 on 04/09/24 | 406.45 on 04/09/24 |
| 1-Month | |||||
| %Chg | +21.57% since 03/15/24 | -1.25% since 03/15/24 | -7.32% since 03/15/24 | -8.06% since 03/15/24 | -2.53% since 03/15/24 |
| Low | 2.36 on 03/21/24 | 264.35 on 04/15/24 | 48.12 on 04/15/24 | 67.62 on 04/12/24 | 393.76 on 04/12/24 |
| High | 3.59 on 04/12/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +37.69% since 01/12/24 | -13.38% since 01/12/24 | -3.58% since 01/12/24 | -21.57% since 01/12/24 | -8.32% since 01/12/24 |
| Low | 1.80 on 02/26/24 | 264.35 on 04/15/24 | 47.58 on 02/06/24 | 67.62 on 04/12/24 | 393.76 on 04/12/24 |
| High | 3.59 on 04/12/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -3.49% since 10/13/23 | -6.54% since 10/13/23 | -14.10% since 10/13/23 | -12.75% since 10/13/23 | +7.11% since 10/13/23 |
| Low | 1.80 on 02/26/24 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 67.62 on 04/12/24 | 341.90 on 11/16/23 |
| High | 3.77 on 11/08/23 | 329.72 on 02/05/24 | 57.65 on 10/17/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,777 | 143,240,432 | 97,851,920 | 84,752,392 | 102,491,920 |
| Shares Outstanding, K | 3,847 | 535,919 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 5,850,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -7,910,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 3,330,985 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -2,501,777 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.14 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 08/29/23 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 6.44 | 10.13 | 29.51 |